Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110a subunit of PI3 kinase.

Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110a subunit of PI3 kinase. Oncotarget. 2015 Apr 10; 6(10):8062-70.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.